首页   按字顺浏览 期刊浏览 卷期浏览 Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients
Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients

 

作者: Abdou Elhendy,   Ron T. van Domburg,   Jos R.T.C. Roelandt,   Marcel L. Geleijnse,   M. Mohsen Ibrahim,   Paolo M. Fioretti,  

 

期刊: Hypertension  (OVID Available online 1997)
卷期: Volume 29, issue 6  

页码: 1232-1239

 

ISSN:0194-911X

 

年代: 1997

 

出版商: OVID

 

数据来源: OVID

 

摘要:

40 mm Hg) during the test was more frequent in hypertensive patients (7% versus 4% in normotensive, P < .05). Independent predictors of hypotension were baseline systolic pressure greater than 140 mm Hg (odds ratio, 6.9; 95% confidence interval, 3.4 to 14), older age (odds ratio, 1.04; 95% confidence interval, 1.01 to 1.07), and medication with calcium channel blockers (odds ratio, 1.8; 95% confidence interval, 1.1 to 3.5). The prevalence of ventricular tachycardia was similar (4.1%) in both groups. Episodes of 10 beats or more (0.06% of patients) were terminated promptly by intravenous metoprolol administration. Dobutamine stress testing was considered feasible in 91% of patients with and 92% of patients without hypertension. Dobutamine-atropine stress echocardiography is a safe and feasible method for the assessment of hypertensive patients referred for evaluation of myocardial ischemia. Despite the higher prevalence of dobutamine-induced hypotension in these patients, the feasibility of the test is comparable to that in individuals without hypertension. (Hypertension. 1997;29:1232-1239.)

 



返 回